Overview
The PNC-27 peptide is a synthetic compound developed to target and destroy cancer cells specifically. By binding to the abnormal cells, it prompts necrosis without affecting normal cells. This selective action is essential for effective cancer treatment, minimizing collateral damage to healthy tissue. The peptide is part of the PNC family and incorporates vital domains from the p53 protein, known for its tumor-suppressing abilities. Researchers are exploring PNC-27’s potential to revolutionize cancer therapies.
Key Features
- Selective targeting of cancer cells
- Promotes necrosis without harming healthy cells
- Incorporates the HDM2 binding domain
- Utilizes key p53 residues for efficacy
- Potential for innovative cancer treatment methods
Specifications
| Item | Description |
|---|---|
| Name | PNC-27 |
| Weight | 5mg |
| Category | Biotech Peptides |
FAQ
What is PNC-27?
PNC-27 is a synthetic peptide designed to target and kill cancer cells while leaving healthy cells unharmed. It functions by inducing cell necrosis specifically in malformed cells.
How does PNC-27 work?
This peptide binds to abnormal cancer cells and activates mechanisms that lead to cell death, essentially bypassing normal, healthy cells.
Where can I use PNC-27?
PNC-27 is ideal for research purposes and may have potential applications in therapeutic settings for cancer treatment. Explore more about our N-Acetyl Selank and other peptides to complement your studies.
If you’re looking to enhance your research or therapeutic approach, consider adding PNC-27 to your collection of biotech peptides. Shop PNC-27 now and take a significant step in your scientific pursuits.
Related Products
Browse more in Biotech Peptides.

Acetyl Hexapeptide-3 (Argireline) (200mg) 

